Janux Therapeutics (JANX) PT Raised to $53 at Wedbush
Tweet
Share
E-mailGet Alerts JANX Hot Sheet
Price: $16.67 +0.91%
Rating Summary:
14 Buy, 4 Hold, 1 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 12 | Down: 19 | New: 8
Rating Summary:
14 Buy, 4 Hold, 1 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 12 | Down: 19 | New: 8
Join SI Premium – FREE
Wedbush analyst Robert Driscoll raised the price target on Janux Therapeutics (NASDAQ: JANX) to $53.00 (from $24.00) while maintaining a Outperform rating.
You May Also Be Interested In
- Samvardhana Motherson International (MOTHERSO:IN) PT Raised to INR170 at JPMorgan
- Citi Downgrades DHL Group (DHL:GR) to Neutral
- Marvell (MRVL) PT Raised to $195 at Goldman Sachs
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
